Claypoole Robert E bought BVS
March 13, 2026 · Form 4 insider transaction
Claypoole Robert E bought 309,000 shares of Bioventus Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
309,000
Price
$0.00
Total value
N/A
InsiderClaypoole Robert E
Role—
CompanyBioventus Inc. (BVS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 13, 2026
Filing dateMarch 17, 2026
Shares owned after309,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date.